TRAITEMENT DE TUMEURS DU SEIN AVEC UN DÉRIVÉ DE RAPAMYCINE EN COMBINAISON AVEC UN INHIBITEUR DE L'AROMATASE
- 专利权人:
- Novartis AG
- 发明人:
- 申请号：
- EP18181342.9
- 公开号：
- EP3406249A1
- 申请日:
- 2002.02.18
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要：
- 40-O-(2-hydroxyethyl)-rapamycin is used to treat hormone receptor positive breast tumors in combination with an aromatase inhibitor.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Application of 40-O-(2-hydroxyethyl)-rapamycin for treatment of solid kidney tumors
- The treatment is for the treatment of brain.
- DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE &bgr；2 ADRENERGIC RECEPTOR
- MESYLATE SALT OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO}-1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE B2 ADRENERGIC RECEPTOR
- Treatment of solid kidney tumors with a rapamycin derivative
